Company Overview

Bud Genius, Inc. (OTC: RIGH) is a publicly traded company historically associated with the cannabis testing, analytics, and intellectual property segment of the legal cannabis industry. Public disclosures and OTC market materials describe the company as having pursued business activities related to cannabis strain identification, laboratory analytics, consumer-facing cannabis classification systems, and cannabis-related branding technologies. The company has also been associated with efforts to develop standardized testing methodologies and data-driven cannabis product categorization tools intended for growers, dispensaries, and consumers.

Available public information indicates that the company’s operational scale, reporting consistency, and active business status have varied over time. Historical filings and market disclosures suggest that the company attempted to position itself within the emerging regulated cannabis ecosystem during the expansion of state-level legalization initiatives in the United States. However, recent independently verifiable operational detail is limited, and some historical business claims cannot be fully confirmed through current public filings. Data inconclusive based on available public sources.

Business Operations

Historically, Bud Genius, Inc. described its operations as centered on cannabis analytics, intellectual property development, and laboratory-related services. Publicly available disclosures referenced activities involving cannabis strain verification, genomic-style classification systems, laboratory testing concepts, and licensing opportunities tied to cannabis identification methodologies. Revenue generation appeared to have been expected from service agreements, licensing arrangements, cannabis-related testing services, and technology commercialization initiatives, although independently verified recurring revenue information is limited in recent periods.

The company’s publicly discussed operations were primarily focused within the United States, particularly in jurisdictions with legalized medical or recreational cannabis frameworks. Available records do not clearly confirm substantial international operations, material long-term joint ventures, or large-scale operating subsidiaries. Historical references to partnerships and cannabis industry collaborations exist in promotional materials and market communications, but several of these relationships cannot be comprehensively verified through current SEC reporting records. Data inconclusive based on available public sources.

Strategic Position & Investments

The company historically sought to differentiate itself through cannabis data standardization and intellectual property positioning. Strategic objectives described in historical materials included creating recognizable cannabis classification systems, supporting consumer product consistency, and building analytical tools that could potentially serve dispensaries and cultivators operating in fragmented state-regulated markets. The broader strategic rationale appeared aligned with increasing demand for product verification, quality control, and strain authentication within the legal cannabis sector.

Public records do not currently demonstrate evidence of large-scale acquisitions, major institutional investments, or materially diversified portfolio holdings comparable to larger cannabis industry operators. While historical announcements referenced technology initiatives and commercialization efforts, the extent of implementation and market adoption remains difficult to independently verify through recent audited disclosures or updated SEC filings. Data inconclusive based on available public sources.

Geographic Footprint

Available disclosures indicate that Bud Genius, Inc. primarily focused on the United States cannabis market. Historical activity appears connected to cannabis-friendly regulatory environments, particularly in western U.S. states where medical or recreational cannabis frameworks expanded during the company’s operational development period. Publicly available information does not clearly establish a significant operational footprint across Europe, Asia, Latin America, or other international markets.

The company’s headquarters location and operational infrastructure have changed over time in historical records, and some public databases contain inconsistent information regarding active offices and operating facilities. No substantial evidence was identified in publicly available filings indicating major foreign subsidiaries, extensive multinational operations, or large international investment programs. Data inconclusive based on available public sources.

Leadership & Governance

Publicly available governance information for Bud Genius, Inc. is limited and appears inconsistent across historical filings, OTC disclosures, and third-party databases. The company has experienced periods of limited reporting visibility, making comprehensive verification of current executive leadership difficult. Historical records suggest management involvement from executives associated with cannabis commercialization and public-market corporate development activities, but several leadership details could not be independently confirmed through recent filings.

Key publicly referenced executives and officers associated with historical company records include:

• Todd Davis – Former executive and public representative associated with company operations
• Scott Sandelman – Historical executive leadership reference in public market materials

The company’s historical strategic messaging emphasized participation in the regulated cannabis economy through data analytics, intellectual property development, and cannabis product standardization concepts. However, the current governance structure, board composition, and executive leadership status cannot be conclusively verified based on presently available public sources.